Chemed (CHE) to Release Earnings on Wednesday

Chemed (NYSE:CHE) will post its quarterly earnings results after the market closes on Wednesday, February 14th. Analysts expect Chemed to post earnings of $2.27 per share for the quarter.

Shares of Chemed (CHE) opened at $252.50 on Wednesday. The stock has a market cap of $4,030.00, a PE ratio of 56.24 and a beta of 1.13. The company has a debt-to-equity ratio of 0.15, a current ratio of 0.50 and a quick ratio of 0.48. Chemed has a 12 month low of $165.15 and a 12 month high of $275.83.

A number of equities research analysts have recently issued reports on the stock. ValuEngine lowered shares of Chemed from a “buy” rating to a “hold” rating in a research note on Friday, December 1st. Zacks Investment Research upgraded shares of Chemed from a “hold” rating to a “buy” rating and set a $251.00 target price on the stock in a research note on Thursday, November 2nd. Royal Bank of Canada upped their target price on shares of Chemed to $232.00 and gave the company a “sector perform” rating in a research note on Tuesday, October 31st. TheStreet upgraded shares of Chemed from a “c+” rating to an “a-” rating in a research note on Friday, October 27th. Finally, Oppenheimer upped their target price on shares of Chemed from $220.00 to $225.00 and gave the company an “outperform” rating in a research note on Friday, October 27th. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $236.00.

In related news, insider Nicholas Michael Westfall sold 10,000 shares of the stock in a transaction dated Monday, November 13th. The shares were sold at an average price of $231.00, for a total transaction of $2,310,000.00. Following the sale, the insider now owns 13,351 shares in the company, valued at $3,084,081. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Spencer S. Lee sold 1,000 shares of the stock in a transaction dated Wednesday, November 15th. The stock was sold at an average price of $232.27, for a total transaction of $232,270.00. Following the sale, the insider now owns 35,809 shares in the company, valued at approximately $8,317,356.43. The disclosure for this sale can be found here. In the last 90 days, insiders sold 31,529 shares of company stock worth $7,446,966. Company insiders own 4.90% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This report was first reported by American Banking News and is the property of of American Banking News. If you are accessing this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this report can be accessed at https://www.americanbankingnews.com/2018/02/07/chemed-che-to-release-earnings-on-wednesday.html.

About Chemed

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.

Earnings History for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply